Loading...

Majuba Hill Copper Corp.

JUBAFPNK
$0.01
$-0.00(-13.79%)
U.S. Market is Open • 15:51

Majuba Hill Copper Corp. Fundamental Analysis

Majuba Hill Copper Corp. (JUBAF) shows weak financial fundamentals with a PE ratio of -0.11, profit margin of 0.00%, and ROE of -75.69%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position73.69%
PEG Ratio-0.00
Current Ratio2.17

Areas of Concern

ROE-75.69%
Operating Margin0.00%
We analyze JUBAF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -57.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-57.4/100

We analyze JUBAF's fundamental strength across five key dimensions:

Efficiency Score

Weak

JUBAF struggles to generate sufficient returns from assets.

ROA > 10%
-64.72%

Valuation Score

Excellent

JUBAF trades at attractive valuation levels.

PE < 25
-0.11
PEG Ratio < 2
-0.00

Growth Score

Weak

JUBAF faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

JUBAF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
2.17

Profitability Score

Weak

JUBAF struggles to sustain strong margins.

ROE > 15%
-7568.57%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is JUBAF Expensive or Cheap?

P/E Ratio

JUBAF trades at -0.11 times earnings. This suggests potential undervaluation.

-0.11

PEG Ratio

When adjusting for growth, JUBAF's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Majuba Hill Copper Corp. at 0.07 times its book value. This may indicate undervaluation.

0.07

EV/EBITDA

Enterprise value stands at -0.24 times EBITDA. This is generally considered low.

-0.24

How Well Does JUBAF Make Money?

Net Profit Margin

For every $100 in sales, Majuba Hill Copper Corp. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-75.69 in profit for every $100 of shareholder equity.

-75.69%

ROA

Majuba Hill Copper Corp. generates $-64.72 in profit for every $100 in assets, demonstrating efficient asset deployment.

-64.72%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.14 in free cash annually.

$-0.14

FCF Yield

JUBAF converts -6.33% of its market value into free cash.

-6.33%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.11

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.07

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.17

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.76

vs 25 benchmark

ROA

Return on assets percentage

-0.65

vs 25 benchmark

ROCE

Return on capital employed

-0.66

vs 25 benchmark

How JUBAF Stacks Against Its Sector Peers

MetricJUBAF ValueSector AveragePerformance
P/E Ratio-0.1124.71 Better (Cheaper)
ROE-75.69%887.00% Weak
Net Margin0.00%-99745.00% (disorted) Weak
Debt/Equity0.000.50 Strong (Low Leverage)
Current Ratio2.176.80 Strong Liquidity
ROA-64.72%-6232.00% (disorted) Weak

JUBAF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Majuba Hill Copper Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Cyclical, Commodity, Value

EPS CAGR

N/A

Industry Style: Cyclical, Commodity, Value

FCF CAGR

N/A

Industry Style: Cyclical, Commodity, Value

Fundamental Analysis FAQ